[HTML][HTML] Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA
A Maimaiti, L Jiang, X Wang, X Shi, Y Pei, Y Hao… - Clinical Neurology and …, 2021 - Elsevier
Background Low-grade glioma (LGG) is one of the most common and aggressive
neurological malignant tumors of the central nervous system. Mounting evidence indicates …
neurological malignant tumors of the central nervous system. Mounting evidence indicates …
Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA
A Maimaiti, L Jiang, X Wang, X Shi… - Clinical neurology …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Low-grade glioma (LGG) is one of the most common and aggressive
neurological malignant tumors of the central nervous system. Mounting evidence indicates …
neurological malignant tumors of the central nervous system. Mounting evidence indicates …
Identification and validation of an individualized prognostic signature of lower-grade glioma based on nine immune related long non-coding RNA.
A Maimaiti, L Jiang, X Wang, X Shi, Y Pei… - Clinical Neurology …, 2021 - europepmc.org
Background Low-grade glioma (LGG) is one of the most common and aggressive
neurological malignant tumors of the central nervous system. Mounting evidence indicates …
neurological malignant tumors of the central nervous system. Mounting evidence indicates …